| Health Care Equipment & Supplies Industry | Healthcare Sector | Mr. Thomas A. Braun BA, J.D., L.L.B., LLM CEO | OTC GREY Exchange | CA92346G1046 ISIN |
| US Country | - Employees | - Last Dividend | 23 Jun 2022 Last Split | - IPO Date |
Verisante Technology Inc., originally known as T-Ray Science Inc., underwent a name change in January 2011 and has its origins dating back to 2006. Located in Vancouver, Canada, the company initially made headlines with its innovative approach to cancer diagnostics. Despite its early drive in the design and manufacture of devices aimed at identifying cancer, Verisante Technology Inc. has since transitioned away from active operations in this sector. The shift signifies a notable change in the company's business trajectory, leaving it without significant ongoing projects or operations in the field of cancer diagnostic technology.
During its period of operational activity, Verisante Technology Inc. was known for its contribution to the field of cancer diagnostics through the development of innovative devices. Each product was developed with the aim of improving the accuracy, speed, and non-invasiveness of cancer detection. However, it is important to note that the company currently does not maintain an active product lineup, reflecting its status of not having significant operations.